Cargando…

8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003

The International St Gallen Breast Cancer Conference concentrates almost exclusively on adjuvant, multimodal primary therapy for early breast cancer. Begun 25 years ago, this meeting was initially held every 4 years, but therapeutic progress, new strategies and provocative trials data have accelerat...

Descripción completa

Detalles Bibliográficos
Autores principales: Glen, Hilary, Jones, Robert J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC165020/
https://www.ncbi.nlm.nih.gov/pubmed/12817991
http://dx.doi.org/10.1186/bcr611
_version_ 1782120818884476928
author Glen, Hilary
Jones, Robert J
author_facet Glen, Hilary
Jones, Robert J
author_sort Glen, Hilary
collection PubMed
description The International St Gallen Breast Cancer Conference concentrates almost exclusively on adjuvant, multimodal primary therapy for early breast cancer. Begun 25 years ago, this meeting was initially held every 4 years, but therapeutic progress, new strategies and provocative trials data have accelerated to the extent that conferences are now held biennially. The meeting this year was attended by almost 3000 delegates. Major topics included new prognostic and predictive markers in early breast cancer, the best use of adjuvant chemotherapy and endocrine therapy, and innovations in local surgery and radiation therapy.
format Text
id pubmed-165020
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1650202003-07-12 8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003 Glen, Hilary Jones, Robert J Breast Cancer Res Meeting Report The International St Gallen Breast Cancer Conference concentrates almost exclusively on adjuvant, multimodal primary therapy for early breast cancer. Begun 25 years ago, this meeting was initially held every 4 years, but therapeutic progress, new strategies and provocative trials data have accelerated to the extent that conferences are now held biennially. The meeting this year was attended by almost 3000 delegates. Major topics included new prognostic and predictive markers in early breast cancer, the best use of adjuvant chemotherapy and endocrine therapy, and innovations in local surgery and radiation therapy. BioMed Central 2003 2003-05-30 /pmc/articles/PMC165020/ /pubmed/12817991 http://dx.doi.org/10.1186/bcr611 Text en Copyright © 2003 BioMed Central Ltd
spellingShingle Meeting Report
Glen, Hilary
Jones, Robert J
8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003
title 8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003
title_full 8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003
title_fullStr 8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003
title_full_unstemmed 8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003
title_short 8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003
title_sort 8th international conference: primary therapy of early breast cancer, st gallen, switzerland, march 12–15 2003
topic Meeting Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC165020/
https://www.ncbi.nlm.nih.gov/pubmed/12817991
http://dx.doi.org/10.1186/bcr611
work_keys_str_mv AT glenhilary 8thinternationalconferenceprimarytherapyofearlybreastcancerstgallenswitzerlandmarch12152003
AT jonesrobertj 8thinternationalconferenceprimarytherapyofearlybreastcancerstgallenswitzerlandmarch12152003